Advocating for a cure for Herpes Simplex Virus.
Genetic defects of brain immunity underlying childhood Herpes simples encephalitis In partnership with the HIV Vaccine Trials Network (HVTN), we are starting off the 2025 Advancing Science Series with Dr.Continue reading "World Encephalitis Day Talk"
Dr. Shafat-Fainguelernt is an internal medicine physician and infectious disease specialist from Israel. She graduated from Ben Gurion University Medical School and received further training at the Soroka University MedicalContinue reading "The Immunocompromised Patient and Acyclovir-Resistance"
In partnership with HVTN, Dr. Betsy Harold will lead this talk. Herpes simplex virus type 2 (HSV-2) is one of the most significant factors fueling the global HIV epidemic andContinue reading "Dr. Betsy Harold – Disrupting the HSV:HIV Syndemic"
Laura Gillim, Phd is Medical Science Liaison, Infectious Disease at Labcorp and a Discipline Director for Infectious Disease Immunology. Laura was previously a scientific director in the department of scienceContinue reading "HSV Laboratory Testing: Challenges and Limitations"
We’re excited to announce the release of the Herpes Cure Pipeline 4.0! Join us for the release as we dive into the pipeline. Thank you for your continued patience and supportContinue reading "Herpes Cure Pipeline 4.0 Release"
View Slide Deck from Presentation Dr. Adva Gadoth is the Associate Director of Epidemiology of Infectious Diseases for Moderna’s early stage and latent virus vaccines, including herpes simplex virus (HSV),Continue reading "Updates in Genital Herpes Epidemiology: Prevalence of Diagnosis and Antiviral Treatment Use in the United States"
View Recording Dr. Marius Walter is a virologist and molecular biologist at the Fred Hutch Cancer Center in Seattle, WA. His research focuses on herpesviruses and invented a new therapeuticContinue reading "HSV Updates – Fred Hutch"
Join us for a powerful and honest conversation bridging the gap between healthcare professionals and the herpes patient community. This unique panel brings together leading voices in HSV education, advocacy,Continue reading "HSV Patient-Provider Panel"
David Camerini is the Director of Virology at ImmPORT Therapeutics/DBA Antigen Discovery Register Here
Join us as we host Assembly Bio for an in-depth discussion on recurrent genital herpes (RGH). This talk will provide an overview of RGH epidemiology, real-world disease burden, and impactContinue reading "Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation."
Despite the fact that 48% of people between 14 and 49 in the US are infected with HSV 1, and one in eight adults is infected with HSV-2, many peopleContinue reading "How Clinicians and Patients Talk about Herpes: Bridging the Disconnect"
Please join us as Dr. Friedman discusses the goals of his phase 1 human trials in herpes vaccines. He will also discuss the innovations that led to the current vaccineContinue reading "Genital Herpes Vaccine Development: The Friedman Lab’s Approach at UPenn"